The company expects the emergency-medicine destocking impact to be behind it in Q4. Management expects Pharma to drive a strong year-end finish and forecasts year-over-year margin improvement.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.